Alterations in Breast Cancer Biomarkers Following Neoadjuvant Therapy.

Mohan, Srivarshini Cherukupalli; Walcott-Sapp, Sarah; Lee, Minna K; Srour, Marissa K; Kim, Sungjin; Amersi, Farin F; Giuliano, Armando E; Chung, Alice P

Mohan, Srivarshini Cherukupalli; Walcott-Sapp, Sarah; Lee, Minna K; Srour, Marissa K; Kim, Sungjin; Amersi, Farin F; Giuliano, Armando E; Chung, Alice P.

Afiliação

Mohan SC; Division of Surgical Oncology, Department of Surgery, Cedars Sinai Medical Center, West Hollywood, CA, USA.
Walcott-Sapp S; Marion-Louise Saltzman Women's Center, Einstein Medical Center Philadelphia, Philadelphia, PA, USA.
Lee MK; Division of Surgical Oncology, Department of Surgery, Cedars Sinai Medical Center, West Hollywood, CA, USA.
Srour MK; Division of Surgical Oncology, Department of Surgery, Cedars Sinai Medical Center, West Hollywood, CA, USA.
Kim S; Biostatistics and Bioinformatics Research Center, Cedars-Sinai Samuel Oschin Comprehensive Cancer Center, Los Angeles, CA, USA.
Amersi FF; Division of Surgical Oncology, Department of Surgery, Cedars Sinai Medical Center, West Hollywood, CA, USA.
Giuliano AE; Division of Surgical Oncology, Department of Surgery, Cedars Sinai Medical Center, West Hollywood, CA, USA.
Chung AP; Division of Surgical Oncology, Department of Surgery, Cedars Sinai Medical Center, West Hollywood, CA, USA. alice.chung@cshs.org.

Ann Surg Oncol ; 28(11): 5907-5917, 2021 Oct.

Article em En | MEDLINE | ID: mdl-33748896

Assuntos

Neoplasias da Mama; Terapia Neoadjuvante; Biomarcadores Tumorais; Neoplasias da Mama/tratamento farmacológico; Feminino; Humanos; Prognóstico; Receptor ErbB-2

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Terapia Neoadjuvante Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google